# DESCRIPTION

## TECHNICAL FIELD

- relate to composition for amelioration of obesity

## BACKGROUND ART

- describe obesity as a major metabolic disease
- discuss current obesity treatments and limitations

## DISCLOSURE

### Technical Problem

- identify need for methods to ameliorate obesity without side effects

### Technical Solution

- provide composition containing phospholipase A2 for prevention or treatment of obesity

### Advantageous Effects

- describe benefits of composition containing phospholipase A2

## DETAILED DESCRIPTION OF THE INVENTION

- define phospholipase A2 (PLA2)
- describe obesity ameliorating efficacy of PLA2
- discuss effects of PLA2 on mannose receptors
- describe effects of PLA2 on hepatic steatosis and kidney inflammation
- discuss effects of PLA2 on metabolic dysfunction
- describe effects of PLA2 on macrophage infiltration
- discuss modulation of M1/M2 macrophage ratio by PLA2
- describe effects of PLA2 on adipogenic factor expressions
- compare obesity inhibitory effect of PLA2 with mellitin
- describe pharmaceutical composition containing PLA2
- discuss formulation of pharmaceutical composition
- describe administration of pharmaceutical composition
- discuss frequency of administration of pharmaceutical composition
- describe health functional food composition containing PLA2

### MODE FOR CARRYING OUT THE INVENTION

- describe test examples for illustrating the present disclosure

### Test Example 1: Increase in Anti-Inflammatory Macrophages by bvPLA2

- describe test example 1

### Test Example 2: Alleviation of Inflammatory Environment by bvPLA2

- describe test example 2

### Test Example 3: Oil Red O Staining

- describe test example 3

### Test Example 4: Experimental Animals

- describe test example 4

### Test Example 5: Regulatory T Cell Depletion (Treg Depletion)

- describe test example 5

### Test Example 6: Quantitative Real-Time PCR

- describe test example 6

### Test Example 7: H&E Staining

- describe test example 7

### Test Example 8: Statistical Analysis

- describe test example 8

## Example 1: Effects of bvPLA2 of Reducing Adipose Tissue Weight and Body Weight

- describe example 1

## Example 2: Influence of bvPLA2 on Body Weight and Adipose Tissue Weight of CD206-Deficient and Regulatory T Cell-Deficient Mice

- investigate immunoregulatory effect of bvPLA2

## Example 3: Hepatotoxicity/Nephrotoxicity Reducing Effects of bvPLA2

### Example 3-1: Effects of bvPLA2 of Ameliorating Hepatic Steatosis and Kidney Damage

- investigate PLA2 alleviating HFD-induced hepatic steatosis and kidney inflammation

### Example 3-2: Metabolic Dysfunction Alleviating Effect of bvPLA2

- investigate effects of bvPLA2 on liver and kidney functions

## Example 4: Effect of bvPLA2 of Inhibiting Macrophage Infiltration in Adipose Tissue

- investigate PLA2 inhibiting macrophage infiltration in WAT

## Example 5: Effects of bvPLA2 of Modulating M1 or M2 Phenotype Markers and Adipogenic Factors

- analyze changes in macrophage phenotypes

### Example 6: Comparison with Mellitin in Bee Venom

- compare mellitin with bvPLA2 in obesity inhibitory effect

